Cite
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections
MLA
Raad, Issam I., et al. “Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections.” Clinical Infectious Diseases, vol. 42, no. 12, June 2006, p. 1726. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.154173851&authtype=sso&custid=ns315887.
APA
Raad, I. I., Graybill, J. R., Bustamante, A. B., Cornely, O. A., Gaona-Flores, V., Afif, C., Graham, D. R., Greenberg, R. N., Hadley, S., Langston, A., Negroni, R., Perfect, J. R., Pitisuttithum, P., Restrepo, A., Schiller, G., Pedicone, L., & Ullmann, A. J. (2006). Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections. Clinical Infectious Diseases, 42(12), 1726.
Chicago
Raad, Issam I., John R. Graybill, Ana Beatriz Bustamante, Oliver A. Cornely, Veronica Gaona-Flores, Claude Afif, Donald R. Graham, et al. 2006. “Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections.” Clinical Infectious Diseases 42 (12): 1726. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.154173851&authtype=sso&custid=ns315887.